Poliomyelitis: Eradication in sight

Epidemiology and Infection

Volumn 108, Issue 1, 1992, Pages 1-18

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VIRUS VACCINE; LIVE VACCINE; POLIOMYELITIS VACCINE;

CONFERENCE PAPER; DISEASE CONTROL; HUMAN; IMMUNIZATION; POLIOMYELITIS; POLIOMYELITIS VIRUS;

AMERICAS; ASIA; BIOLOGY; CANADA; DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DISEASES; EUROPE; FINLAND; GENETICS; HEALTH; HEALTH SERVICES; IMMUNITY; IMMUNIZATION; ISRAEL; LITERATURE REVIEW; MEDITERRANEAN COUNTRIES; NETHERLANDS; NEUROLOGIC EFFECTS; NORTH AMERICA; NORTHERN AMERICA; NORTHERN EUROPE; PHYSIOLOGY; PRIMARY HEALTH CARE; SCANDINAVIA; SWEDEN; UNITED STATES; VACCINES--BENEFICIAL EFFECTS; VACCINES--SIDE EFFECTS; VIRAL DISEASES--PREVENTION AND CONTROL; WESTERN ASIA; WESTERN EUROPE;

DEVELOPING COUNTRIES; HUMAN; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; VACCINATION; WORLD HEALTH;

EID: 0026607750     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268800049451     Document Type: Article

References (60)

1. Melnick J.L. Enteroviruses. In: Evans A.S., ed. Viral infections of humans: epidemiology and control. New York: Plenum, 3rd Ed., 1989: 191–263.
2. Nkowane BM, Wassilak SGF, Orenstein WA, Bart KJ, Schonberger LB, Hinman AR. Vaccine–associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 1987; 257: 1335–40.
3. Horstman DM, Quinn TC, Robbins FC, eds. International Symposium on Poliomyelitis Control. Rev Inf Dis 1984; 6 (Suppl. 2): S301–S600.
4. Centers for Disease Control. Update: Progress toward eradicating poliomyelitis from the Americas. MMWR 1990; 39: 557–61.2116586
5. World Health Organization Expanded Programme on Immunization. Poliomyelitis in. 1987, 1988, 1989, Parts I and II. Weekly Epidem Rec 1991; 66: 49–53, 70–2.
6. Schaap GJP, Bijkerk H, Coutinho RA, Kapsenberg JG, van Wezel AL. The spread of wild poliovirus in the well–vaccinated Netherlands in connection with the 1978 epidemic. Prog Med Virol 1984; 29: 124–49.6322230
7. Hovi T, Huovilainen A, Kuronen T, et al, Outbreak of paralytic poliomyelitis in Finland: Widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986; I: 1427–35.
8. Green MS, Handsher R, Cohen D, et al, Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel: Evidence supporting the need for a booster immunization in adolescents. Submitted for publication. 1991.
9. World Health Organization. Poliomyelitis in 1980, Parts 1 and 2. Weekly Epidem Rec 1981; 56: 329–36; 337–44.
10. World Health Organization. Poliomyelitis in 1985, Parts I and II. Weekly Epidem Rec 1987; 62: 273–80; 281–2.
11. World Health Organization. Poliomyelitis in 1979, Parts I and II. Weekly Epidem Rec 1980; 55: 361–6, 369–76.
12. Pan American Health Organization. Expanded Program on Immunization, Polio surveillance in the Americas. Weekly Bulletin vol. II, 50, for week ending 12 19, 1987.
13. Melnick JL. Advantages and disadvantages of killed and live poliomyelitis vaccines. Bull WHO 1978; 56: 21–38. 307445
14. Stoeckel P, Schlumberger M, Parent G, et al, Use of killed poliovirus vaccine in a routine immunization program in West Africa. Rev Infect Dis 1984; 6 (Suppl. 2): S463–S466.
15. McBean AM, Thoms ML, Albrecht P, Cuthie JC, Bernier R, and the Field Staff Coordinating Committee. The serologic response to oral polio vaccine and enhanced potency inactivated polio vaccines. Am J Epid 1988; 128: 615–28.
16. Centers for Disease Control. Preliminary report: Paralytic poliomyelitis – Senegal, 1986. MMWR 1987; 36: 387–90.
17. WHO 1985.
18. Cockburn WC. The work of the WHO Consultative Group on Poliomyelitis Vaccines. Bull WHO 1988; 66: 143–54.2840219
19. Patriarca PA, Palmeira G, Filho JL, et al, Randomised trial of alternative formulations of oral poliovaccine in Brazil. Lancet 1988; I: 429–33.
20. Lasch EE, Abed Y, Abdulla K, et al, Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza. Rev Infect Dis 1984; 6 (Suppl. 2): S467–S470.6740094
21. Sabin AB. Paralytic poliomyelitis: Old dogmas and new perspectives. Rev Infect Dis 1981; 3: 543–64.6269169
22. Sabin AB. Oral poliovirus vaccine: History of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis 1985; 151: 420–36.2982959
23. Robinson DA. Polio vaccination – a review of strategies. Trans Roy Soc Trop Med & Hyg 1982; 76: 575–81.
24. WHO 1985; 60: 13–16.
25. Foster SO, Kesseng-Maben G, N'jie H., Coffi E. Control of poliomyelitis in Africa. Rev Infect Dis 1984; 6 (Suppl. 2): S433–S437.6740089
26. Henderson RH, Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling methodology. Bull WHO 1982; 60: 253–60.6980735
27. Ofosu-Amaah S, Kratzer JH, Nicholas DD. Is poliomyelitis a serious problem in developing countries? Lameness in Ghanaian schools. BMJ 1977; I: 1012–14.
28. Bernier RH. Prevalence survey techniques for paralytic polio: An update. Expanded Programme on Immunization Working Paper, EPI/GAG 83/10. Geneva, World Health Organization, 1983.
29. Heymann DL, Floyd VD, Luchnevski M, Kesseng-Maben G, Mvongo F. Estimation of incidence of poliomyelitis by three survey methods in different regions of the United Republic of Cameroon. Bull WHO 1983; 61: 501–7.6603923
30. LaForce FM, Lichnevski MS, Keja J, Henderson RH. Clinical survey techniques to estimate prevalence and annual incidence of poliomyelitis in developing countries. Bull WHO 1980; 58: 609–20.6969133
31. Heymann DL, Murphy K, Brigaud M, Aymard M, Tembon A, Maben GK. Oral poliovirus vaccine in tropical Africa. Bull WHO 1987; 65: 495–501. 3500802
32. Melnick JL, Ashkenazi A, Midulla VC, Wallis C, Bernstein A. Immunogenic potency of MgCl2–stabilized oral poliovaccine. JAMA 1963; 185: 406–8.13934730
33. Peetermans J, Colinet G, Stephenne J. Activity of attenuated poliomyelitis and measles vaccines exposed at different temperatures. In: Proceedings Symposium on Stability and Effectiveness of Measles, Poliomyelitis, and Pertussis Vaccines. Zagreb: Yugoslav Academy of Sciences and Arts, 1976: 61–6.
34. Finter NB, Ferris R, Kelly A, Prydie J. Effects of adverse storage on live virus vaccines. Dev Biol Stand 1978; 41: 61–6.
35. Mirchamsy H, Shafyi A, Mahinpour M, Nazari P. Stabilizing effect of magnesium chloride and sucrose on Sabin live polio vaccine. Dev Biol Stand 1978; 41: 255–7.223912
36. World Health Organization Poliomyelitis annual reports for 1974–1985. Weekly Epidem Rec, 1976–1987.
37. Risi JB Jr. The control of poliomyelitis in Brazil. Rev Inf Dis 1984; 6 (Suppl. 2): S400–3.
38. Fernandez de Castro PJ. Comments on the geographic distribution of poliomyelitis in the Americas: Notes for a program on continental eradication of poliomyelitis. (Translation.) Revista Salud Publica de Mexico 1984; 26: (no. 3, 05–06).
39. de Quadros C, Andrus JL, Olive J-M, da Silveira M, et al, Eradication of poliomyelitis: progress in the Americas. Pediat Inf Dis J 1991; 19: 222–9.
40. Dave KH. Report of Enterovirus Research Centre, Bombay, for 1986, published 1987.
41. John TJ. Poliomyelitis in India: Prospects and problems of control. Rev Infect Dis 1984; 6 (Suppl. 2): S438–41.6740090
42. WHO Expanded Programme on Immunization. Contract system tested. Weekly Epidem Rec 1987; 62: 142–3.
43. Melnick JL. Combined use of live and killed vaccines to control poliomyelitis in tropical areas. Dev Biol Stand 1981; 47: 265–73.7227655
44. Goldblum N, Swartz T, Gerichter CB, Handsher R, Lasch EE, Melnick JL. The natural history of poliomyelitis in Israel,1949–1982. Prog Med Virol 1984; Vol 29: 115–23.6366916
45. Slater PE, Orenstein WA, Morag A, et al, Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet 1990; 335: 1192–8.
46. Lasch EE. Abed Y, Marcus O, Gerichter CB, Melnick JL. combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country – five years after. Dev Biol Stand 1986; 63: 137–43.
47. Tulchinsky T, Abed Y, Shaheen S, et al, A ten–year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. Am J Public Hlth 1989; 79: 1648–52.
48. von Magnus H, Petersen I. Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark. Rev Infect Dis 1984; 6 (Suppl. 2): S471–4.6740095
49. Ogra PL, Faden HS, Abraham R, Duffy LC, Sun M, Minor PD. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Inf Dis 1991; 164: 191–4.
50. Hogle MJ, Chow M, Filman JD. Three-dimensional structure of poliovirus at 29 Å resolution. Science 1985; 229: 1358–65.
51. Minor PD, Ferguson M, Evans DMA, Almond JW, Icenogle JP. Antigenic structure of polioviruses of serotypes 1, 2, and 3. J Gen Virol 1986; 67: 1283–91.
52. Wimmer E, Emini EA, Diamond DC. Mapping neutralization domains of viruses. In: Notkins AL, Oldstone MBA, eds. Concepts in clinical pathogenesis, Vol 2. New York: Springer–Verlag, 1986: 159–73.
53. Burke KL, Almond JW, Evans DJ. Antigen chimeras of poliovirus. Prog Med Virol 1991; 38: 56–68. 1647044
54. Chumakov KM, Powers LB, Noonan KE, Roninson IB, Levenbook IS. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci 1991; 88: 199–203.
55. Ren R, Costantini F, Gorgacz EJ, Lee JJ, Racaniello VR. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis. Cell 1990; 63: 353–62.
56. Koike S, Taya C, Kurata T, et al, Transgenic mice susceptible to poliovirus. Proe Natl Acad Sci 1991; 88: 951–5.
57. Rotbart HA. New methods of rapid enteroviral diagnosis. Prog Med Virol 1991; 38: 96–108. 2052736
58. da Silva EE, Pallansch MA, Holloway BP, Oliveira MJC, Schatzmayr HG, Kew OM. Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirol 1991; 32: 149–59.
59. Eggers HJ. Notes on the pathogenesis of enterovirus infections. Med Microbiol Immunol 1990; 179: 297–306.
60. Morrison LA, Fields BN. Parallel mechanisms in neuropathogenesis of enteric virus infections. J Virol 1991; 65: 2767–72.1851851